Key result
Prompt high-dose steroids optimize outcomes in rare, high-mortality immune checkpoint inhibitor myocarditis.
Why the study?
ICI-associated myocarditis is a rare clinical entity with a high mortality rate and variable clinical presentations requiring heightened suspicion in at-risk patients.
Immune checkpoint inhibitor-associated myocarditis is a rare but highly fatal condition with varied presentations, requiring high clinical suspicion and prompt high-dose steroid therapy.
Answers are grounded in this paper and cite their sources.
May support early steroids in suspected ICI myocarditis; leaves open optimal regimens and outcomes in prospective cohorts.
•ICI-associated myocarditis is a rare clinical entity, but one with an exceedingly high mortality rate.•The condition can present with a wide variety of manifestations. Thus, clinical suspicion for the diagnosis should remain elevated in at-risk patients receiving immunotherapy.•Early diagnosis and prompt initiation of high-dose steroids are key to optimizing patient outcomes.
No takes yet. Share an insight, caveat, or question.
Fox et al. (2023) studied this question. Immune checkpoint inhibitor-associated myocarditis is a rare, high-mortality condition with variable presentations requiring early diagnosis and prompt high-dose steroids to optimize outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: